Inventor
NGUYEN MARGARET THY LUU
US12 patents
Patents
12 patentsUS9562073B2Feb 7, 2017
Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof
CYTOMX THERAPEUTICS INC32 citations95
US10138272B2Nov 27, 2018
Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof
CYTOMX THERAPEUTICS INC31 citations93
US9487590B2Nov 8, 2016
Activatable antibodies that bind interleukin-6 receptor and methods of use thereof
CYTOMX THERAPEUTICS INC15 citations92
US11046759B2Jun 29, 2021
Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof
CYTOMX THERAPEUTICS INC4 citations84
US11028126B2Jun 8, 2021
Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof
CYTOMX THERAPEUTICS INC8 citations83
US10611845B2Apr 7, 2020
Activatable antibodies that bind interleukin-6 receptor and methods of use thereof
CYTOMX THERAPEUTICS INC2 citations72
US12459999B2Nov 4, 2025
Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof
CYTOMX THERAPEUTICS INC0 citations62
US11884746B2Jan 30, 2024
Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof
CYTOMX THERAPEUTICS INC0 citations62
US11548944B2Jan 10, 2023
Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof
CYTOMX THERAPEUTICS INC0 citations62
US11548943B2Jan 10, 2023
Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof
CYTOMX THERAPEUTICS INC0 citations62
US11472875B1Oct 18, 2022
Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof
CYTOMX THERAPEUTICS INC0 citations62
US11814410B2Nov 14, 2023
Matrix metalloproteinase substrates and other cleavable moieties and methods of use thereof
CYTOMX THERAPEUTICS INC0 citations59